Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 4/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.33 |
| ▸ | ABL1 | P00519 | 2/20 | 0.33 |
| ▸ | EGFR | P00533 | 2/20 | 0.33 |
| ▸ | HCK | P08631 | 2/20 | 0.33 |
| ▸ | KDR | P35968 | 2/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.33 |
| ▸ | MTOR | P42345 | 2/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.33 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.33 |
| ▸ | PRKDC | P78527 | 2/20 | 0.33 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.33 |
| ▸ | PDE5A | O76074 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31728368 | 0.90 | — | — | |
| SCHEMBL31728401 | 0.88 | SRC (0.39) | SRCPIK3CDABL1EGFRHCK | |
| SCHEMBL31728341 | 0.82 | SRC (0.34) | SRCPIK3CDABL1EGFRHCK | |
| SCHEMBL31728831 | 0.82 | — | — | |
| SCHEMBL31728749 | 0.81 | PIK3CD (0.30) | SRCPIK3CDABL1EGFRHCK | |
| SCHEMBL31727872 | 0.81 | SRC (0.35) | SRCPIK3CDABL1EGFRHCK | |
| SCHEMBL31727804 | 0.80 | SRC (0.37) | SRCPIK3CDABL1EGFRHCK | |
| SCHEMBL31728229 | 0.80 | HTT (0.34) | SRCPIK3CDABL1EGFRHCK | |
| SCHEMBL31727961 | 0.79 | — | — | |
| SCHEMBL31728101 | 0.77 | SRC (0.34) | SRCPIK3CDABL1EGFRHCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235874-A1 | HETEROCYCLICS AS EGFR INHIBITORS | SCHRÖDINGER, INC. (US) | 2025-11-13 | — | — | WO | disclosed |